Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Freya Meds review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Three clearly labeled commitment tiers per molecule — Monthly at $297/mo semaglutide and $390/mo tirzepatide, with cheaper Quarterly and Annual prepay options — undercut by homepage marketing that headlines the deepest-commitment $150/mo annual rate, a named clinician's title that doesn't match her own bio, and a 450,000-patient reach claim that's self-reported rather than verified.

$297/mo
Flat price · every dose
Consult Medication Coaching
See plans at Freya Meds
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Freya Meds at a glance

Semaglutide
$297/mo
Tirzepatide
$390/mo
Coverage
50 states (self-reported; no exclusion list published)
Brand-name
Compounded only

How we scored Freya Meds

Every factor comes from Freya Meds's own published pricing, disclosures and oversight, and the six combine into the 48/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance20/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit55/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs50/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost55/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support68/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness50/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: $297/mo; tirzepatide: $390/mo. Lower annual and quarterly monthly equivalents require longer plans; monthly billing costs $297 or $390.

Before you sign up

What Freya Meds's public site and signup page show before you hand over any details.

Worth knowing

  • Homepage and /pricing list three commitment tiers per molecule — Annual, Quarterly, Monthly — each clearly labeled with its own price; no toggle or guesswork needed to read them
  • The homepage anchors its marketing on the Annual (12-month prepay) rate — "Plans from as little as $150/month" — rather than the no-commitment Monthly rate
  • A "Meet Your Care Team" section names two clinicians directly on the page
  • One named clinician is titled "Lead Physician" in the role label but described in the same sentence as an NP with 8 years of GLP-1 experience — a title inconsistency we're flagging rather than silently resolving either way
  • Claims "450,000+ patients across 50 U.S. states" on its homepage — a first-party marketing claim, not independently verified beyond the site's own text
  • We did not find the standard "not FDA-approved, compounded" disclaimer sentence verbatim on the pages we checked — that means we didn't see it, not that it isn't there

Pricing

MedicationPricePlan
Compounded semaglutide$297Monthly (no commitment)Monthly billing $297.
Compounded semaglutide$250Quarterly planQuarterly plan $250/month equivalent; three-month commitment.
Compounded semaglutide$150Annual plan (12-month prepay)Annual plan $150/month equivalent; annual prepayment.
Compounded tirzepatide$390Monthly (no commitment)Monthly billing $390.
Compounded tirzepatide$333Quarterly planQuarterly plan $333/month equivalent; three-month commitment.
Compounded tirzepatide$249Annual plan (12-month prepay)Annual plan $249/month equivalent; annual prepayment.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Freya Meds's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Three clearly labeled commitment tiers per molecule on its own pricing page, with no ambiguous toggle state to guess at
  • Unlimited doctor consultations, monthly group calls, and a one-on-one dietitian consultation bundled into every tier, per its own site
  • States "Cancel anytime" on its pricing page
  • Names two clinicians directly on a team page rather than leaving oversight anonymous

The caveats

  • The homepage's headline "$150/month" marketing figure is the deepest-commitment, 12-month prepay rate — the no-commitment monthly price is $297/mo semaglutide, $390/mo tirzepatide
  • One named clinician's title is inconsistent on its own page — labeled "Lead Physician" but described as a nurse practitioner in the same sentence
  • Its "450,000+ patients across 50 states" reach claim is self-reported marketing copy, not independently verified
  • We could not find the standard compounded/not-FDA-approved disclaimer sentence on the pages checked
  • No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
  • Compounded only — no brand-name option and no oral form

The monthly tier is substantially above the annual headline

Freya Meds publishes semaglutide at $297 monthly, with quarterly and annual equivalents of $250 and $150. Tirzepatide is $390 monthly, $333 quarterly and $249 annually. The lowest homepage figure therefore belongs to the deepest commitment rather than a flexible monthly purchase. Someone who wants a smaller initial decision should compare $297 or $390, then evaluate the longer terms separately. Ask for the actual payment schedule and total obligation attached to the selected tier rather than assume every monthly equivalent is collected without commitment.

The price ladder is clearly labeled, which makes the tradeoff easier to examine than an unexplained starting figure. The important remaining question is what happens when a patient needs to stop, pause or change medication during a longer plan. Cancel-anytime language should not be expanded into an automatic refund of unused prepaid treatment. Obtain the selected agreement's renewal amount, cancellation cutoff and handling of unshipped supply. A long-term discount is most useful after the proposed prescription and continuing care arrangement are understandable, rather than simply because the annual average is lower.

Dietitian contact and group calls are tangible inclusions

Freya says every tier includes unlimited doctor consultations, monthly group calls and an individual dietitian consultation. Those features can matter to someone who wants nutritional support alongside prescribing. Ask how the individual visit is booked, whether it repeats and what the group calls cover. A group session, educational material and ongoing individual counseling are different services. The value depends on the contact a patient can actually use, especially when childcare or work makes scheduled sessions difficult to attend.

Unlimited consultations likewise need a practical explanation of access, appointment format and responsibility. Ask which professional manages the prescription and how a medication question is handled between planned contacts. A promise of access does not guarantee an immediate physician response or a requested treatment. The medication menu is compounded injectable care rather than an established oral or approved-brand alternative, so formulation preferences should be resolved before choosing a long term. An active ingredient appearing in an approved brand does not make Freya's compounded preparation the same finished product.

The clinician's professional role needs clarification

Freya names Sienna Steckel as Lead Physician while describing her as a nurse practitioner, and separately names Christopher Findley as Consulting Physician. The inconsistent description should be clarified rather than used to invent credentials or dismiss the professional. Ask who treats the individual patient and what their actual role and licensure are. Named people provide a useful starting point, but a title on a team page does not establish who conducts every assessment or remains responsible for follow-up.

The company claims reach across fifty states and a large patient count; those are company-reported statements rather than independent evidence of outcomes or personal eligibility. Confirm the actual clinical and pharmacy arrangement for the patient's address. The available material does not provide substantive postpartum, breastfeeding or PCOS guidance, so relevant needs require direct discussion. Freya's attraction is a readable tier ladder with defined support features. Its decision should use the selected commitment, confirmed professional roles and operational care terms, keeping the $150 annual headline separate from the much higher monthly option.

The bottom line for mothers

Best for: Mothers comfortable prepaying a full year for the lowest number, who want unlimited consultations, group calls and a dietitian bundled into every tier.

Alternatives to Freya Meds

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.

    Visit Willow
  • Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.

    Visit Sprout Health

Providers like Freya Meds

Keep comparing Freya Meds

Freya Meds, answered

Is Freya Meds' $150/month price the real ongoing rate?
No — that's the Annual plan, paid 12 months upfront. The no-commitment Monthly rate, which is what most new patients actually pay before deciding to commit longer, is $297/mo for semaglutide and $390/mo for tirzepatide. A Quarterly tier sits in between at $250/mo and $333/mo.
Who prescribes at Freya Meds?
Two named clinicians appear on its "Meet Your Care Team" page: Dr. Sienna Steckel and Dr. Christopher Findley. Worth knowing: Dr. Steckel is labeled "Lead Physician" in the role title but described in the same sentence as a nurse practitioner with 8 years of GLP-1 experience — an inconsistency on Freya's own page that we're recording rather than resolving for you.
Does Freya Meds serve my state?
It claims "450,000+ patients across 50 U.S. states" on its homepage, but that's a self-reported marketing figure, and we found no published state-exclusion list to check it against. Confirm your own state directly with Freya Meds before paying.

Pricing, states and verification reflect Freya Meds's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers